Kimberly Renee Thomas, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 805 N Whittington Pkwy, Louisville, KY 40222 Phone: 502-627-7000 |
Zelda Valadez-sanchez, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 805 N Whittington Pkwy, Louisville, KY 40222 Phone: 502-627-7000 |
Ms. Michelle Lynne Sankowsky, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 805 N Whittington Pkwy, Louisville, KY 40222 Phone: 502-627-7000 |
News Archive
A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In laboratory tests of rectal tissue, researchers from the Microbicide Trials Network (MTN) found that the reformulated gel was less harmful to the lining of the rectum than the original vaginal formulation, and just as effective in protecting cells against HIV.
During a joint press conference with Indian Prime Minister Manmohan Singh on Monday, President Barack Obama announced a new partnership between U.S. and Indian agriculture sectors to help improve food security globally, Press Trust International/Livemint.com reports.
Although people infected with HIV produce many antibodies against the protein encapsulating the virus, most of these antibodies are strangely ineffective at fighting the disease. A new study suggests why some of the most common of these antibodies don't work: they target the protein in a form it takes after the virus has already invaded the cell, when it's too late, report researchers at Children's Hospital Boston and their colleagues.
Numerous experts and policy makers have called for hospitals to screen patients for methicillin-resistant Staphylococcus aureus (MRSA) infections and isolate anyone testing positive to prevent the spread of these so-called "Superbugs" in healthcare settings.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received a Humanitarian Use Device (HUD) designation from the Food and Drug Administration (FDA) for its CryoValve® SG aortic human heart valve.
› Verified 2 days ago